Levomilnacipran

Amneal Pharmaceuticals LLC🇺🇸 United States

FDA Page

Effective Date: Nov 16, 2023
Approval ID: bcbc5d92-e022-4a0d-ab4d-2b0d7aa68c58
Products: 4 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LEVOMILNACIPRAN EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for LEVOMILNACIPRAN EXTENDED-RELEASE CAPSULES. LEVOMILNACIPRAN extended-release capsules, for oral use Initial U.S. Approval: 2009 (milnacipran)

Quick Stats

Total Products4

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.